← Leaderboards
Haitao Hu
Henry M. Jackson Fdn For The Adv Mil/Med
$4,700,400
Attributed
$4,700,400
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $902K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,700,400 · 5
By mechanism
R01$3,008,635 · 1
R21$837,812 · 2
R56$553,986 · 1
R41$299,967 · 1
Top collaborators
No co-investigators on record.
Most similar at Henry M. Jackson Fdn For The Adv Mil/Med
Same institution · by research overlap
- Courtney Lynn Vaughan$61,346
Others in their field
Top investigators on “Pandemic Disease”
- Lawrence Corey · Fred Hutchinson Cancer Center$577,650,512
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$367,690,681
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$293,301,957
- Peter B. Gilbert · Fred Hutchinson Cancer Center$193,124,118
- Richard Webby · St. Jude Children'S Research Hospital$175,384,418
- Georgia D Tomaras · Fred Hutchinson Cancer Center$122,341,809
Research focus
Pandemic DiseaseT-LymphocyteCd4 Positive T LymphocytesPeripheral Blood Mononuclear CellProteinsIn VitroInfectionCellsLeadMolecularNovel StrategiesPathway InteractionsBaseIn VivoTranscriptomicsBindingFutureMediatingLaboratoriesAntigensGenetic TranscriptionChromatinChromatin StructureGenome
Grant awards (12)
Modulation of BRD4 to epigenetically suppress HIV$902,028
R01 · FY2025 · AI · contact PI
Modulation of BRD4 to epigenetically suppress HIV$601,727
R01 · FY2024 · AI · contact PI
Development of a Pan-COVID-19 Vaccine Candidate$299,967
R41 · FY2024 · AI · contact PI
Modulation of BRD4 to epigenetically suppress HIV$301,426
R01 · FY2023 · AI · contact PI
Modulation of BRD4 to epigenetically suppress HIV$601,727
R01 · FY2022 · AI · contact PI
Modulation of BRD4 to epigenetically suppress HIV$601,727
R01 · FY2021 · AI · contact PI
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV$197,500
R21 · FY2021 · AI · contact PI
In vitro and in vivo analysis of susceptibility of Ad26 vector-induced CD4 T cells to HIV/SIV$237,000
R21 · FY2020 · AI · contact PI
Modulation of BRD4 to epigenetically suppress HIV$553,986
R56 · FY2019 · AI · contact PI
Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci$139,500
R21 · FY2015 · AI · contact PI
Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci$46,516
R21 · FY2015 · AI · contact PI
Susceptibility of antigen-specific CD4 T cells to HIV: implications for HIV vacci$217,296
R21 · FY2014 · AI · contact PI